Biotechnology company Moderna (NASDAQ:MRNA) gained the spotlight in the medical sector as a leader in the race toward a COVID-19 vaccine. Its messenger RNA (mRNA) technology garnered acclaim as a ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

Germany's leading source of electric power generation got a big boost in 2024, according to latest industry figures. Regulators approved more than 2,400 new onshore wind turbines with a total ...

Concerns about GBS arose during the review of safety data from clinical trials prior to the approval of Abrysvo (manufactured by Pfizer) and Arexvy (manufactured by GlaxoSmithKline), according to ...

First discovered in the Netherlands roughly 24 years ago, HMPV belongs to the same viral family as RSV. Human metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but ...

LONDON, GREATER LONDON, UNITED KINGDOM, January 22, 2025 /EINPresswire / -- What has been the historic growth trend in the abrysvo or arexvy global market and what is expected in the coming years?

BERLIN ― Ukraine is pushing to get those of its citizens who have sought refuge in Germany to return home as Kyiv’s war with Russia nears its third anniversary. With more than a million Ukrainians ...

According to the FDA, the benefits of vaccination with Abrysvo and Arexvy continue to outweigh the potential risks. To assess the risk of GBS with these vaccines, the FDA conducted a postmarketing ...

Shares were also aided by a successful US and European launch of Arexvy, a respiratory syncytial virus (RSV) vaccine for older adults. Although risks around the Zantac litigation remain a concern ...

Shares were also aided by a successful US and European launch of Arexvy, a respiratory syncytial virus (RSV) vaccine for older adults. Although risks around the Zantac litigation remain a concern ...